Back to top anchor

Implementing HPV primary testing to prevent cervical cancer in NZ: Te Tai Tokerau

48 months
Approved budget:
Professor Beverley Lawton
Dr Evelyn MacDonald
Ms Anna Adcock
Professor Stacie Geller
Dr Kendall Stevenson
Associate Professor Jo-Ann Stanton
Associate Professor Peter Sykes
Associate Professor Marion Saville
Associate Professor David Hawkes
Dr Nokuthaba Sibanda
Professor Merilyn Hibma
Health issue:
Cancer (oncology)
Proposal type:
Health Delivery Project
Lay summary
The World Health Organization has called for the global elimination of cervical cancer. Two major technologies will contribute to this aim. The first is HPV vaccination, which is already offered to all adolescents through the school vaccination programme. The second is testing for the HPV virus. HPV primary screening is more effective in detecting cervical changes and will prevent a further 15% of new cancers when compared to cytology. Our work has shown that HPV self-testing is very acceptable to under-screened Māori women. There are important questions that need to be answered before a national programme of HPV primary screening is implemented in NZ. This project, “Te Tai Tokerau”, is designed to investigate effective implementation strategies working alongside district health boards, primary care, communities and the Ministry of Health. The objective is an informed efficient primary HPV screening programme to reduce cervical cancer incidence and death in NZ.